CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-10 | Henry Andrew VP, Clinical Operations | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2017-06-10 | DUNN JOHN MICHAEL General Counsel and Secretary | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2017-06-10 | Ashley Robert A. Chief Technical Officer, EVP | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2017-06-09 | Ashley Robert A. Chief Technical Officer, EVP | Purchase | +2,000 | $3.18 | $6K | 2,000 |
| 2017-06-09 | Satter Muneer A Director | Purchase | +10,000 | $3.17 | $32K | 10,922,277 |
| 2017-06-08 | Satter Muneer A Director | Purchase | +10,000 | $3.10 | $31K | 10,912,277 |
| 2017-06-08 | Nash Duane President | Purchase | +3,900 | $3.12 | $12K | 8,224 |
| 2017-06-07 | Satter Muneer A Director | Purchase | +10,000 | $3.21 | $32K | 10,902,277 |
| 2017-06-06 | Satter Muneer A Director | Purchase | +10,000 | $3.19 | $32K | 10,892,277 |
| 2017-05-23 | Satter Muneer A Director | Grant or award · Stock Option (right to buy) | +63,031 | 63,031 | ||
| 2017-05-23 | STEER RANDOLPH C Director | Grant or award · Stock Option (right to buy) | +45,022 | 45,022 |
Page 16 of 16 · 311 trades